Table 3.
Summary of metabolic side product formation for different oxygen levels.
| O2 | Strain | Gluconate (mM) | 2-Ketogluconate (mM) | Acetate (mM) | PHAs (C10 + C12)a (μg/mgCDW) |
|---|---|---|---|---|---|
| I | WT (no electrode) | 0.37 ± 0.18 | 0.18 ± 0.08 | 0.75 ± 1.30 | 15.2 ± 0.4 |
| I | WT | 0.58 ± 0.13 | 0.09 ± 0.03 | 0 | 3.3 ± 0.8 |
| I | pPhz | 0.55 ± 0.11 | 0.06 ± 0.08 | 0.17 ± 0.05 | 4.8 ± 2.5 |
| II | WT | 0.83 ± 0.13 | 0.29 ± 0.28 | 1.22 ± 0.12 | 7.3 ± 5.3 |
| II | pPhz | 1.74 ± 0.13 | 1.77 ± 0.20 | 0.47 ± 0.50 | 5.8 ± 1.5 |
| III | WT | 0.14 ± 0.03 | 0.10 ± 0.01 | 0 | 3.7 ± 3.5 |
| III | pPhz | 2.86 ± 2.67 | 0.48 ± 0.52 | 0.28 ± 0.49 | 2.9 ± 0.5 |
| III- | pPhz | 0.42 ± 0.18 | 3.80 ± 2.16 | 0 | 1.0 ± 2.2 |
a
sum of poly-3-hydroxy-decanoate, C10, and poly-3-hydroxy-dodecanoate, C12.